Skip to content

Clinical trials

Completed Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Status: Completed Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20071
20081
20101
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
NCIC Clinical Trials Group2
European Organisation for Research and Treatment of Cancer - EORTC1
Inex Pharmaceuticals1
London Health Sciences Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma8
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, Large-Cell, Anaplastic6
Burkitt Lymphoma5
Lymphoma5
Lymphoma, Large-Cell, Immunoblastic5
Lymphoma, Non-Hodgkin5
Waldenstrom Macroglobulinemia5
Hodgkin Disease4
Immunoblastic Lymphadenopathy4

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.